Navigation Links
SynergEyes Reports Minor Interruption at Manufacturing Facility
Date:10/24/2013

CARLSBAD, Calif., Oct. 24, 2013 /PRNewswire/ -- SynergEyes, manufacturer and marketer of hybrid contact lenses, reported a minor interruption at its manufacturing facility in the 2200 block of Rutherford Road on Tuesday, October 22nd. The disruption occurred when a small amount of vapor was released inside the building due to a chemical reaction of an unknown cause. The facility was immediately evacuated and the Carlsbad Fire Department notified.

(Logo: http://photos.prnewswire.com/prnh/20131024/LA04236LOGO)

The fire department quickly neutralized the source of the vapor and cleared the facility for re-entry. There was no chemical spill of any kind and no injuries to SynergEyes employees or anyone in adjoining buildings. The Carlsbad Fire Department believes there was no threat of environmental damage as a result of the incident.

"We have a safety system for dealing with hazardous waste and that system operated exactly as it was designed to do. It contained the chemicals, with no spills or leaks whatsoever, and vented the fumes to prevent any other danger," said Steve Ziemba, Vice President of Quality and Clinical Affairs. "We evacuated the building and contacted the Carlsbad Fire Department due to an abundance of caution when the incident was discovered and are pleased that there were no adverse events resulting from this."

The company resumed manufacturing operations today and will continue to investigate the cause of the event.

"We are committed to operating a safe work environment and take all practical precautions to ensure that hazards and accidents do not occur," says Dr. James K. Kirchner, President and CEO of SynergEyes. "Although this incident did not result in any personal injury or put the local community in jeopardy, we consider this to be a serious matter and pledge to take any and all corrective action necessary to prevent future mishaps."

Headquartered in Carlsbad, California, SynergEyes, Inc. was founded in 2001 to develop a contact lens that would combine the superior visual quality of a gas permeable lens with the comfort and ease of wear of a soft contact lens. The revolutionary SynergEyes hybrid contact lenses allow patients to enjoy the best of both worlds – consistently crisp vision and all-day comfort. SynergEyes holds numerous U.S. patents, along with FDA market clearances for the entire family of SynergEyes, Duette and UltraHealth contact lenses. The patented SynergEyes technology is currently available through more than 5,000 eye care practitioners worldwide.


'/>"/>
SOURCE SynergEyes
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
3. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
4. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
7. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
8. Luminex Corporation Reports First Quarter 2012 Results
9. Hospira Reports First-Quarter 2012 Results
10. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
11. The Female Health Company Reports Second Quarter Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... , Aug. 15, 2017 AccuGenomics, Inc., a ... , today announced that the company has provided an ... of North Carolina at Chapel Hill and to Qura ... to characterize and quantify HIV reservoir and viral expression ... intervention. The HIV Cure Center is a joint initiative ...
(Date:8/8/2017)...  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company ... results for the second quarter ended June 30, 2017. ... 2017 and to date: ... the Company,s lead project, BL-8040: Announced ... as novel stem cell mobilization treatment for autologous bone-marrow ...
(Date:8/7/2017)... Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent specialty pharmacy, ...  All comparisons, unless otherwise noted, are to the quarter ended ... Second Quarter 2017 Highlights include: Revenue ... 3.5% Total prescriptions dispensed of 220,000, compared ... 7.6% Gross profit per prescription dispensed ...
Breaking Medicine Technology:
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... , ... August 18, 2017 ... ... Quick International, LLC (“Quick”), a highly specialized asset-light logistics provider of complex ... into a definitive agreement to purchase Unitrans International Corporation, a division of ...
(Date:8/18/2017)... ... 18, 2017 , ... As an industry leader, Eppendorf is ... will present the line of epMotion automated liquid handling system. This automated liquid ... everyday pipetting tasks. , Ideal for scientists and lab technicians with no or ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, a Houston ... east Texas, is launching a regional charity effort to provide publicity assistance and ... Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 million in donations that ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... The Golseth ... in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized to provide ... , In early June of this year, Christina and her children returned from out ...
Breaking Medicine News(10 mins):